Travelers Companies Reports Strong Core Income and Underwriting Gains for Q2 2026, Driven by Premium Growth and Improved Combined Ratio
Travelers Companies, Inc. Reports Strong Q2 2026 Results: Re...
Sign in to continue:
Travelers Companies, Inc. Reports Strong Q2 2026 Results: Re...
Lisata Therapeutics 8-K Filing: Amendment to Merger Agreemen...
Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Res...
NutryFarm International: Key Announcements on Amended Agreem...
Uniti Group Inc. - Key Developments July 2026 Uniti...
IREIT Global Provides Update on Berlin Campus Litigation I...
South Plains Financial, Inc. Reports Q2 2026 Financial Resul...
F.N.B. Corporation Reports Record Q2 2026 Results: Key Highl...
Cocrystal Pharma, Inc. - Annual Meeting Results and Key Shar...
Polaryx Therapeutics, Inc. Announces Date for 2026 Annual Me...